L-Tryptophan in the Treatment of Restless Legs Syndrome
1986; American Psychiatric Association; Volume: 143; Issue: 4 Linguagem: Inglês
10.1176/ajp.143.4.554-b
ISSN1535-7228
Autores Tópico(s)Parkinson's Disease Mechanisms and Treatments
ResumoBack to table of contents Previous article Next article ArticleNo AccessL-Tryptophan in the Treatment of Restless Legs SyndromeREUVEN SANDYKREUVEN SANDYKSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.143.4.554-bAboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "L-Tryptophan in the Treatment of Restless Legs Syndrome." American Journal of Psychiatry, 143(4), pp. 554-b–555 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byEffects of Opioid Antagonists on l-DOPA-Induced Dyskinesia in Parkinson's DiseaseJournal of Neural Transmission, Vol. 115, No. 3European Journal of Neurology, Vol. 13, No. 10Levetiracetam Interferes With the l-Dopa Priming Process in MPTP-Lesioned Drug-Naive MarmosetsClinical Neuropharmacology, Vol. 27, No. 4Movement Disorders, Vol. 19, No. 5, Vol. 51, Vol. 52Expert Review of Neurotherapeutics, Vol. 2, No. 3Nature Reviews Neuroscience, Vol. 2, No. 8Calcium channel antagonists for the treatment of bipolar disorder24 December 2001 | Bipolar Disorders, Vol. 2, No. 2European Journal of Pain, Vol. 4, No. 3CNS Drugs, Vol. 13, No. 5Synapse, Vol. 33, No. 4European Journal of Neuroscience, Vol. 10, No. 8Journal of Clinical Psychopharmacology, Vol. 18, No. 1Annals of Neurology, Vol. 42, No. 5Neurologic Clinics, Vol. 14, No. 3Human Psychopharmacology: Clinical and Experimental, Vol. 10, No. 4International Journal of Neuroscience, Vol. 78, No. 1-2Movement Disorders, Vol. 8, No. 4Review of L-tryptophan and eosinophilia-myalgia syndromeJournal of the American Dietetic Association, Vol. 92, No. 7International Journal of Neuroscience, Vol. 67, No. 1-4International Journal of Neuroscience, Vol. 46, No. 3-4International Journal of Neuroscience, Vol. 47, No. 3-4International Journal of Neuroscience, Vol. 48, No. 1-2International Journal of Neuroscience, Vol. 49, No. 1-2International Journal of Neuroscience, Vol. 39, No. 1-2International Journal of Neuroscience, Vol. 42, No. 3-4International Journal of Neuroscience, Vol. 30, No. 4 Volume 143Issue 4 April 1986Pages 554-b-555 Metrics PDF download History Published online 1 April 2006 Published in print 1 April 1986
Referência(s)